Ross Levine on Blood Cancer, Cancer Genetics, and New Therapies

Source briefing · A concise briefing based on one linked source. It is intentionally shorter than a full FreedomWitness Evidence Engine analysis.

What the source reports

Ross L. Levine, MD, Chief Scientific Officer at Memorial Sloan Kettering Cancer Center, joins The Future of Medicine for a conversation about blood cancer, cancer genetics, and how a laboratory discovery can eventually lead to new treatments.More than 20 years ago, Levine helped discover a genetic change in JAK2, a gene that plays an important role in controlling blood cell growth.

When JAK2 is altered in certain ways, the signal that tells blood cells to grow can become stuck in the “on”…

Evidence note: At this stage FreedomWitness is presenting what this source reports. This briefing does not independently prove every underlying claim and should be read together with the original material.

Source & verification

Primary source: The Future of Medicine · August 23, 2026

Read the original source

FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.